Literature DB >> 9020040

Angiotensin II stimulates the proliferation of osteoblast-rich populations of cells from rat calvariae.

Y Hiruma1, A Inoue, S Hirose, H Hagiwara.   

Abstract

We examined the effects of angiotensin II (Ang II) on the proliferation of osteoblast-rich populations of cells obtained from calvariae of newborn rat. Addition of Ang II to the culture medium caused dose-dependent increases in the rate of DNA synthesis. Such increases were completely inhibited by the addition of DuP753, an antagonist of AT1 receptor. Ang II potentiated the production of inositol 1,4,5-trisphosphate (IP3) in the culture. Ang II also stimulated the activities of mitogen-activated protein kinases (MAPKs) upon binding to the AT1 receptor. These results suggest that Ang II might be intimately involved in the proliferation of the cells in calvariae through the AT1 receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020040     DOI: 10.1006/bbrc.1996.5914

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice.

Authors:  Y Zhang; L Wang; Y Song; X Zhao; M S Wong; W Zhang
Journal:  Osteoporos Int       Date:  2015-10-06       Impact factor: 4.507

2.  Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation - role of a local renin-angiotensin system.

Authors:  P Garcia; S Schwenzer; J E Slotta; C Scheuer; A E Tami; J H Holstein; T Histing; M Burkhardt; T Pohlemann; M D Menger
Journal:  Br J Pharmacol       Date:  2010-03-05       Impact factor: 8.739

3.  Does the use of ACE inhibitors or angiotensin receptor blockers affect bone loss in older men?

Authors:  T Kwok; J Leung; Y F Zhang; D Bauer; K E Ensrud; E Barrett-Connor; P C Leung
Journal:  Osteoporos Int       Date:  2011-11-12       Impact factor: 4.507

4.  Continuous infusion of angiotensin II modulates hypertrophic differentiation and apoptosis of chondrocytes in cartilage formation in a fracture model mouse.

Authors:  Hirohisa Kawahata; Daisuke Sotobayashi; Motokuni Aoki; Hideo Shimizu; Hironori Nakagami; Toshio Ogihara; Ryuichi Morishita
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

5.  Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes.

Authors:  Teng-Yue Diao; Hai Pan; Sa-Sa Gu; Xi Chen; Fang-Yi Zhang; Man-Sau Wong; Yan Zhang
Journal:  J Bone Miner Metab       Date:  2013-08-10       Impact factor: 2.626

6.  Relationship between blood pressure levels and bone mineral density in postmenopausal Turkish women.

Authors:  Selma Yazici; Mehmet Yazici; Ugur Korkmaz; Melih Engin Erkan; Ali Erdem Baki; Ismail Erden; Hakan Ozhan; Safinaz Ataoğlu
Journal:  Arch Med Sci       Date:  2011-05-17       Impact factor: 3.318

7.  Locally administrated perindopril improves healing in an ovariectomized rat tibial osteotomy model.

Authors:  Xiong Zhao; Zi-xiang Wu; Yang Zhang; Ming-xuan Gao; Ya-bo Yan; Peng-chong Cao; Yuan Zang; Wei Lei
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

Review 8.  Vascular calcification and renal bone disorders.

Authors:  Kuo-Cheng Lu; Chia-Chao Wu; Jen-Fen Yen; Wen-Chih Liu
Journal:  ScientificWorldJournal       Date:  2014-07-17

9.  Angiotensin (1-7) ameliorates the structural and biochemical alterations of ovariectomy-induced osteoporosis in rats via activation of ACE-2/Mas receptor axis.

Authors:  Hatem M Abuohashish; Mohammed M Ahmed; Dina Sabry; Mahmoud M Khattab; Salim S Al-Rejaie
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

10.  Systemic treatment with telmisartan improves femur fracture healing in mice.

Authors:  Xiong Zhao; Jia-xing Wang; Ya-fei Feng; Zi-xiang Wu; Yang Zhang; Lei Shi; Quan-chang Tan; Ya-bo Yan; Wei Lei
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.